DrugPatentWatch Database Preview

Dow Pharm Company Profile

DOW PHARM has nine approved drugs.

There is one US patent protecting DOW PHARM drugs.

There are twenty-eight patent family members on DOW PHARM drugs in twenty-two countries and eighteen supplementary protection certificates in thirteen countries.

International Patents:	28
US Patents:	1
Tradenames:	7
Ingredients:	7
NDAs:	9
Patent Litigation for Dow Pharm:	See patent lawsuits for Dow Pharm

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	080443-003	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018		RX	Yes	Yes		Start Trial				Start Trial
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	087644-001	Aug 24, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018		RX	Yes	Yes	6,517,847	Start Trial	Y			Start Trial
Dow Pharm	DOW-ISONIAZID	isoniazid	TABLET;ORAL	080330-002	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	QUIDE	piperacetazine	TABLET;ORAL	013615-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	SANSAC	erythromycin	SOLUTION;TOPICAL	062522-001	Jan 24, 1985		DISCN	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	5,670,547	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Brazil	0113247	Start Trial
South Korea	20080036246	Start Trial
Portugal	1304992	Start Trial
Portugal	2052714	Start Trial
World Intellectual Property Organization (WIPO)	0211683	Start Trial
South Africa	200301037	Start Trial
Australia	2001279002	Start Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	C300617	Netherlands	Start Trial	PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
0809498	10C0038	France	Start Trial	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0617614	11/2001	Austria	Start Trial	PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011
1304992	PA2013025	Lithuania	Start Trial	PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
0617614	C300043	Netherlands	Start Trial	PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011
1304992	PA2013025,C1304992	Lithuania	Start Trial	PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992	2013/044	Ireland	Start Trial	PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.